Genetically Engineered HSV-1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Engineered HSV-1, covering 2024-02-02 to 2024-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma [Phase 1]